Current protocols in the generation of pluripotent stem cells: Theoretical, methodological and clinical considerations

Stem Cells and Cloning: Advances and Applications

Volumn 3, Issue 1, 2010, Pages 13-27

  Swelstad, Brad B ^a   Kerr, Candace L ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Derivation; Human; Pluripotency; Stem cells

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

CELL DIFFERENTIATION; CELL NUCLEUS TRANSPLANTATION; EMBRYO DEVELOPMENT; EMBRYONAL CARCINOMA STEM CELL; EMBRYONIC STEM CELL; FERTILIZATION IN VITRO; GENE EXPRESSION; HUMAN; NONHUMAN; PARTHENOGENESIS; PLURIPOTENT STEM CELL; PRIMORDIAL GERM CELL; REVIEW; SOMATIC CELL;

EID: 77957361890     PISSN: None     EISSN: 11786957     Source Type: Journal    
DOI: None     Document Type: Review

References (192)

1. Stevens LC. Development of resistance to teratocarcinogenesis by primordial germ cells in mice. J Natl Cancer Inst. 1966;37(6):859-867.
2. Andrews PW. Teratocarcinomas and human embryology: pluripotent human EC cell lines. Review article. Apmis. 1998;106(1):158-167.
3. Stevens LC. Origin of testicular teratomas from primordial germ cells in mice. J Natl Cancer Inst. 1967;38(4):549-552.
4. Yu J, Thomson JA. Pluripotent stem cell lines. Genes Dev. 2008;22(15):1987-1997.
5. Eguizabal C, Shovlin TC, Durcova-Hills G, Surani A, McLaren A. Generation of primordial germ cells from pluripotent stem cells. Differentiation. 2009;78(2-3):116-123.
6. Yu Z, Ji P, Cao J, et al. Dazl promotes germ cell differentiation from embryonic stem cells. J Mol Cell Biol. 2009;1(2):93-103.
7. Haston KM, Tung JY, Reijo Pera RA. Dazl functions in maintenance of pluripotency and genetic and epigenetic programs of differentiation in mouse primordial germ cells in vivo and in vitro. PLoS One. 2009;4(5):e5654.
8. Geijsen N, Horoschak M, Kim K, Gribnau J, Eggan K, Daley GQ. Derivation of embryonic germ cells and male gametes from embryonic stem cells. Nature. 2004;427(6970):148-154.
9. Hubner K, Fuhrmann G, Christenson LK, et al. Derivation of oocytes from mouse embryonic stem cells. Science. 2003;300(5623):1251-1256.
10. Nayernia K, Nolte J, Michelmann HW, et al. In vitro-differentiated embryonic stem cells give rise to male gametes that can generate offspring mice. Dev Cell. 2006;11(1):125-132.
11. Toyooka Y, Tsunekawa N, Akasu R, Noce T. Embryonic stem cells can form germ cells in vitro. Proc Natl Acad Sci U S A. 2003;100(20):11457-11462.
12. Lacham-Kaplan O, Chy H, Trounson A. Testicular cell conditioned medium supports differentiation of embryonic stem cells into ovarian structures containing oocytes. Stem Cells. 2006;24(2):266-273.
13. Kerkis A, Fonseca SA, Serafim RC, et al. In vitro differentiation of male mouse embryonic stem cells into both presumptive sperm cells and oocytes. Cloning Stem Cells. 2007;9(4):535-548.
14. Clark AT, Bodnar MS, Fox M, et al. Spontaneous differentiation of germ cells from human embryonic stem cells In vitro. Hum Mol Genet. 2004;13(7):727-739.
15. Aflatoonian B, Moore H. Human primordial germ cells and embryonic germ cells, and their use in cell therapy. Curr Opin Biotechnol. 2005;16(5):530-535.
16. Kee K, Gonsalves JM, Clark AT, Pera RA. Bone morphogenetic proteins induce germ cell differentiation from human embryonic stem cells. Stem Cells Dev. 2006;15(6):831-837.
17. Tilgner K, Atkinson SP, Golebiewska A, Stojkovic M, Lako M, Armstrong L. Isolation of primordial germ cells from differentiating human embryonic stem cells. Stem Cells. 2008;26(12):3075-3085.
18. Park TS, Galic Z, Conway AE, et al. Derivation of primordial germ cells from human embryonic and induced pluripotent stem cells is significantly improved by coculture with human fetal gonadal cells. Stem Cells. 2009;27(4):783-795.
19. West FD, Machacek DW, Boyd NL, Pandiyan K, Robbins KR, Stice SL. Enrichment and differentiation of human germ-like cells mediated by feeder cells and basic fibroblast growth factor signaling. Stem Cells. 2008;26(11):2768- 2776.
20. Bucay N, Yebra M, Cirulli V, et al. A novel approach for the derivation of putative primordial germ cells and sertoli cells from human embryonic stem cells. Stem Cells. 2009;27(1):68-77.
21. Zhao XY, Li W, Lv Z, et al. iPS cells produce viable mice through tetraploid complementation. Nature. 2009;461(7260):86-90.
22. Nagy A, Gocza E, Diaz EM, et al. Embryonic stem cells alone are able to support fetal development in the mouse. Development. 1990;110(3):815-821.
23. Thomson JA. Embryonic stem cell lines derived from human blastocysts. [comment][erratum appears in Science 1998 4;282(5395):1827]. Science. 1998;282(5391):1145-1147.
24. Shamblott MJ, Axelman J, Wang S, et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci U S A. 1998;95(23):13726-13731.
25. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;292(5819):154-156.
26. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in media conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A. 1981;78:7634-7638.
27. Smith AG. Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol. 2001;17:435-462.
28. Amit M, Itskovitz-Eldor J. Derivation and maintenance of human embryonic stem cells. In: Turksen T, editor. Methods in Molecular Biology, Volume 331: Human Embryonic Stem Cell Protocols. New York: Humana Press; 2006. p. 43-53.
29. Sullivan S, Cowan CA, Eggan K, editors. Human Embryonic Stem Cells: The Practical Handbook. West Sussex: John Wiley and Sons, Ltd; 2007,
30. Klimanskaya I, Lanza R, editors. Methods in Enzymology, Volume 418: Embryonic Stem Cells. San Diego: Academic Press; 2006.
31. Lerou PH, Yabuuchi A, Huo H, et al. Derivation, growth and applications of human embryonic stem cells from poor-quality in vitro fertilization embryos. Reproduction. 2004;128(3):259-267.
32. Lerou PH, Yabuuchi A, Huo H, et al. Derivation and maintenance of human embryonic stem cells from poor-quality in vitro fertilization embryos. Reprod Biomed Online. 2008;3(5):923-933.
33. Bavister B. Oxygen concentration and preimplantation development. Reprod Biomed Online. 2004;9(5):484-486.
34. Ezashi T, Das P, Roberts RM. Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci U S A. 2005;102(13):4783-4788.
35. Forsyth NR, Musio A, Vezzoni P, Simpson AH, Noble BS, McWhir J. Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities. Cloning Stem Cells. 2006;8(1):16-23.
36. Yoshida Y, Takahashi K, Okita K, Ichisaka T, Yamanaka S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell. 2009;5(3):237-241.
37. Lerou PH, Yabuuchi A, Huo H, et al. Derivation and maintenance of human embryonic stem cells from poor-quality in vitro fertilization embryos. Nat Protoc. 2008;3(5):923-933.
38. Cowan CAV, Svetlakov AV, Polstianoy AM, et al. Derivation of a novel human embryonic stem-cell line under serum-free and feeder-free conditions. Dokl Biol Sci. 2004;350(13):1353-1356.
39. Ludwig TE, Bergendahl V, Levenstein ME, Yu J, Probasco MD, Thomson JA. Feeder-independent culture of human embryonic stem cells. Nat Methods. 2006;3(8):637-646.
40. Ludwig TE, Levenstein ME, Jones JM, et al. Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol. 2006;24(2):185-187.
41. Kim C, Amano T, Park J, Carter MG, Tian X, Yang X. Improvement of embryonic stem cell line derivation efficiency with novel medium, glucose concentration, and epigenetic modifications. Cloning Stem Cells. 2009;11(1):89-100.
42. Tsuji-Takayama K, Inoue T, Ijiri Y, et al. Demethylating agent, 5-azacytidine, reverses differentiation of embryonic stem cells. Biochem Biophys Res Commun. 2004;323(1):86-90.
43. Lee JH, Hart SR, Skalnik DG. Histone deacetylase activity is required for embryonic stem cell differentiation. Genesis. 2004;38(1):32-38.
44. Feng B, Ng JH, Heng JC, Ng HH. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell. 2009;4(4):301-312.
45. Lee H, Park J, Forget BG, Gaines P. Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells. Regen Med. 2009;4(5):759-769.
46. Amabile G, Meissner A. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med. 2009;15(2):59-68.
47. Kiuru M, Boyer JL, O'Connor TP, Crystal RG. Genetic control of wayward pluripotent stem cells and their progeny after transplantation. Cell Stem Cell. 2009;4(4):289-300.
48. Feng B, Jiang J, Kraus P, et al. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat Cell Biol. 2009;11(2):197-203.
49. Huangfu D, Osafune K, Maehr R, et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol. 2008;26(11):1269-1275.
50. Mali P, Ye Z, Hommond HH, et al. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells. 2008;26(8):1998-2005.
51. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science. 2008;322(5903):945-949.
52. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science. 2008;322(5903):949-953.
53. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature. 2009;458(7239):771-775.
54. Woltjen K, Michael IP, Mohseni P, et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 2009;458(7239):766-770.
55. Kim D, Kim CH, Moon JI, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell. 2009;4(6):472-476.
56. Mikkelsen TS, Hanna J, Zhang X, et al. Dissecting direct reprogramming through integrative genomic analysis. Nature. 2008;454(7200):49-55.
57. Shi Y, Do JT, Desponts C, Hahm HS, Scholer HR, Ding S. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell. 2008;2(6):525-528.
58. Marson A, Foreman R, Chevalier B, et al. Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell. 2008;3(2):132-135.
59. Silva J, Barrandon O, Nichols J, Kawaguchi J, Theunissen TW, Smith A. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 2008;6(10):e253.
60. Li W, Wei W, Zhu S, et al. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell. 2009;4(1):16-19.
61. Palii SS, Van Emburgh BO, Sankpal UT, Brown KD, Robertson KD. DNA methylation inhibitor 5-Aza-2′-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B. Mol Cell Biol. 2008;28(2):752-771.
62. Brockes JP, Kumar A. Plasticity and reprogramming of differentiated cells in amphibian regeneration. Nat Rev Mol Cell Biol. 2002;3(8):566-574.
63. Byrne JA, Nguyen HN, Reijo Pera RA. Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts. PLoS One. 2009;4(9):e7118.
64. Yamanaka S. Elite and stochastic models for induced pluripotent stem cell generation. Nature. 2009;460(7251):49-52.
65. Hong H, Takahashi K, Ichisaka T, et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature. 2009;460(7259):1132-1135.
66. Banito A, Rashid ST, Acosta JC, et al. Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev. 2009;23(18):2134-2139.
67. Eguchi G, Okada TS. Differentiation of lens tissue from the progeny of chick retinal pigment cells cultured in vitro: a demonstration of a switch of cell types in clonal cell culture. Proc Natl Acad Sci U S A. 1973;70(5):1495-1499.
68. Xie H, Ye M, Feng R, Graf T. Stepwise reprogramming of B cells into macrophages. Cell. 2004;117(5):663-676.
69. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature. 2008;455(7213):627- 632.
70. Baker TG, Franchi LL. The fine structure of oogonia and oocytes in human ovaries. J Cell Sci. 1967;2(2):213-224.
71. Sun EL, Gondos B. Squash preparation studies of germ cells in human fetal testes. J Androl. 1984 Sep;5(5):334-338.
72. Makabe S, Naguro T, Motta PM. A new approach to the study of ovarian follicles by scanning electron microscopy and ODO maceration. Arch Histol Cytol. 1992;55 Suppl:183-190.
73. Heyn R, Makabe S, Motta PM. Ultrastructural dynamics of human testicular cords from 6 to 16 weeks of embryonic development. Study by transmission and high resolution scanning electron microscopy. Ital J Anat Embryol. 1998;103(4 Suppl 1):17-29.
74. Bendsen E, Byskov AG, Laursen SB, Larsen HP, Andersen CY, Westergaard LG. Number of germ cells and somatic cells in human fetal testes during the first weeks after sex differentiation. Hum Reprod. 2003;18(1):13-18.
75. Francavilla S, Cordeschi G, Properzi G, Concordia N, Cappa F, Pozzi V. Ultrastructure of fetal human gonad before sexual differentiation and during early testicular and ovarian development. J Submicrosc Cytol Pathol. 1990;22(3):389-400.
76. Witschi E. Embryology of the Ovary. In: Grady HG, Smith DE, editors. The Ovary. Baltimore: Williams and Wilkins; 1963:1-10.
77. Wartenberg H. Development of the early human ovary and role of the mesonephros in the differentiation of the cortex. Anat Embryol (Berl). 1982;165(2):253-280.
78. Gondos B, Hobel CJ. Ultrastructure of germ cell development in the human fetal testis. Z Zellforsch Mikrosk Anat. 1971;119(1):1-20.
79. Labosky PA, Hogan BL. Mouse primordial germ cells: isolation and in vitro culture. Methods Mol Biol. 2008;461:187-199.
80. Dolci S, Pesce M, De Felici M. Combined action of stem cell factor, leukemia inhibitory factor, and cAMP on in vitro proliferation of mouse primordial germ cells. Mol Reprod Dev. 1993;35(2):134-139.
81. Hua J, Yu H, Liu S, et al. Derivation and characterization of human embryonic germ cells: serum-free culture and differentiation potential. Reprod Biomed Online. 2009;19(2):238-249.
82. Godin I, Wylie CC. TGF beta 1 inhibits proliferation and has a chemotropic effect on mouse primordial germ cells in culture. Development. 1991;113(4):1451-1457.
83. Matsui Y, Toksoz D, Nishikawa S, et al. Effect of Steel factor and leukaemia inhibitory factor on murine primordial germ cells in culture. Nature. 1991;353(6346):750-752.
84. Dolci S, Williams DE, Ernst MK, et al. Requirement for mast cell growth factor for primordial germ cell survival in culture. Nature. 1991;352(6338):809-811.
85. Labosky PA, Barlow DP, Hogan BL. Embryonic germ cell lines and their derivation from mouse primordial germ cells. Ciba Found Symp. 1994;182:157-168.
86. Niwa H, Burdon T, Chambers I, Smith A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 1998;12(13):2048-2060.
87. Shamblott MJ, Kerr CL, Axelman J, et al. Derivation and Differentiation of Human Embryonic Germ Cells. In: Lanza R, Hogan B, Melton D, Pedersen R, Thomson J, West M, ed. Handbook of Stem Cells. Vol 1. New York: Elsevier Academic Press; 2004:459-469.
88. De Felici M, Dolci S, Pesce M. Proliferation of mouse primordial germ cells in vitro: a key role for cAMP. Dev Biol. 1993;157(1):277-280.
89. Resnick JL, Bixler LS, Cheng L, Donovan PJ. Long-term proliferation of mouse primordial germ cells in culture. Nature. 1992;359(6395):550-551.
90. Matsui Y, Zsebo K, Hogan BL. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell. 1992;70(5):841-847.
91. Guan K, Nayernia K, Maier LS, et al. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature. 2006;440(7088):1199-1203.
92. Izadyar F, Pau F, Marh J, et al. Generation of multipotent cell lines from a distinct population of male germ line stem cells. Reproduction. 2008;135(6):771-784.
93. Kanatsu-Shinohara M, Inoue K, Lee J, et al. Generation of pluripotent stem cells from neonatal mouse testis. Cell. 2004;119(7):1001-1012.
94. Conrad S, Renninger M, Hennenlotter J, et al. Generation of pluripotent stem cells from adult human testis. Nature. 2008;456(7220):344-349.
95. Kossack N, Meneses J, Shefi S, et al. Isolation and characterization of pluripotent human spermatogonial stem cell-derived cells. Stem Cells. 2009;27(1):138-149.
96. Ko K, Tapia N, Wu G, et al. Induction of pluripotency in adult unipotent germline stem cells. Cell Stem Cell. 2009;5(1):87-96.
97. Kossack N, Meneses J, Shefi S, et al. Isolation and characterization of pluripotent human spermatogonial stem cell-derived cells. Stem Cells. 2009;27(1):138-149.
98. Dym M, He Z, Jiang J, Pant D, Kokkinaki M. Spermatogonial stem cells: unlimited potential. Reprod Fertil Dev. 2009;21(1):15-21.
99. Oatley JM, Brinster RL. Spermatogonial stem cells. Methods Enzymol. 2006;419:259-282.
100. Kanatsu-Shinohara M, Takehashi M, Shinohara T. Brief history, pitfalls, and prospects of mammalian spermatogonial stem cell research. Cold Spring Harb Symp Quant Biol. 2008;73:1 7-23.
101. Rougier N, Werb Z. Minireview: Parthenogenesis in mammals. Mol Reprod Dev. 2001;59(4):468-474.
102. Revazova ES, Turovets NA, Kochetkova OD, et al. Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells. 2007;9(3):432-449.
103. Cibelli JB, Cunniff K, Vrana KE. Embryonic stem cells from parthenotes. Methods Enzymol. 2006;418:117-135.
104. Surani MA, Barton SC, Norris ML. Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature. 1984;308(5959):548-550.
105. McGrath J, Solter D. Inability of mouse blastomere nuclei transferred to enucleated zygotes to support development in vitro. Science. 1984;226(4680):1317-1319.
106. Kono T, Obata Y, Wu Q, et al. Birth of parthenogenetic mice that can develop to adulthood. Nature. 2004;428{6985):860-864.
107. Wu Q, Kumagai T, Kawahara M, et al. Regulated expression of two sets of paternally imprinted genes is necessary for mouse parthenogenetic development to term. Reproduction. 2006;131(3):481-488.
108. Strain L, Warner JP, Johnston T, Bonthron DT. A human parthenogenetic chimaera. Nat Genet. 1995;11(2):164-169.
109. Revazova ES, Turovets NA, Kochetkova OD, et al. HLA Homozygous Stem Cell Lines Derived from Human Parthenogenetic Blastocysts. Cloning Stem Cells. 2008;10(1):11-24.
110. Hao J, Zhu W, Sheng C, Yu Y, Zhou Q. Human parthenogenetic embryonic stem cells: one potential resource for cell therapy. Sci China C Life Sci. 2009;52(7):599-602.
111. Allen ND, Barton SC, Hilton K, Norris ML, Surani MA. A functional analysis of imprinting in parthenogenetic embryonic stem cells. Development. 1994;120(6):1473-1482. (Pubitemid 24175890)
112. Kim K, Lerou P, Yabuuchi A, et al. Histocompatible embryonic stem cells by parthenogenesis. Science. 2007;315(5811):482-486. (Pubitemid 46178390)
113. Thomson JA, Solter D. The developmental fate of androgenetic, parthenogenetic, and gynogenetic cells in chimeric gastrulating mouse embryos. Genes Dev. 1988;2(10):1344-1351.
114. Mai Q, Yu Y, Li T, et al. Derivation of human embryonic stem cell lines from parthenogenetic blastocysts. Cell Res. 2007;17(12):1008-1019. (Pubitemid 350261798)
115. Lin G, OuYang Q, Zhou X, et al. A highly homozygous and parthenogenetic human embryonic stem cell line derived from a onepronuclear oocyte following in vitro fertilization procedure. Cell Res. 2007;17(12):999-1007. (Pubitemid 350261797)
116. Hwang WS, Roh SI, Lee BC, et al. Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science. 2005;308(5729):1777-1783.
117. Kim K, Ng K, Rugg-Gunn PJ, et al. Recombination signatures distinguish embryonic stem cells derived by parthenogenesis and somatic cell nuclear transfer. Cell Stem Cell. 2007;1(3):346-352. (Pubitemid 47355324)
118. De Sousa PA, Gardner J, Sneddon S, et al. Clinically failed eggs as a source of normal human embryo stem cells. Stem Cell Res. 2009;2(3):188-197.
119. Lin H, Lei J, Wininger D, et al. Multilineage potential of homozygous stem cells derived from metaphase II oocytes. Stem Cells. 2003;21(2):152-161. (Pubitemid 36331758)
120. Revazova ES, Turovets NA, Kochetkova OD, et al. HLA homozygous stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells. 2008;10(1):11-24. (Pubitemid 351341546)
121. Suss-Toby E, Gerecht-Nir S, Amit M, Manor D, Itskovitz-Eldor J. Derivation of a diploid human embryonic stem cell line from a mononuclear zygote. Hum Reprod. 2004;19(3):670-675. (Pubitemid 38344534)
122. McElroy SL, Kee K, Tran N, Menses J, Giudice LC, Reijo Pera RA. Developmental competence of immature and failed/abnormally fertilized human oocytes in nuclear transfer. Reprod Biomed Online. 2008;16(5):684-693. (Pubitemid 351721739)
123. Xing F, Fang Z, Qin B, Li Y, Hou J, Chen X. Parthenogenetic embryonic stem cells derived from cryopreserved newborn mouse ovaries: a new approach to autologous stem cell therapy. Fertil Steril. 2009;91(4):1238-1244.
124. de Fried EP, Ross P, Zang G, et al. Human parthenogenetic blastocysts derived from noninseminated cryopreserved human oocytes. Fertil Steril. 2008;89(4):943-947. (Pubitemid 351491233)
125. Muller R, Lengerke C. Patient-specific pluripotent stem cells: promises and challenges. Nat Rev Endocrinol. 2009;5(4):195-203.
126. Eckardt S, Leu NA, Bradley HL, Kato H, Bunting KD, McLaughlin KJ. Hematopoietic reconstitution with androgenetic and gynogenetic stem cells. Genes Dev. 2007;21(4):409-419. (Pubitemid 46310177)
127. Koh CJ, Delo DM, Lee JW, et al. Parthenogenesis-derived multipotent stem cells adapted for tissue engineering applications. Methods. 2009;47(2):90-97.
128. Sanchez-Pernaute R, Lee H, Patterson M, et al. Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease. Brain. 2008;131(Pt 8):2127-2139.
129. Bongso A, Fong CY, Gauthaman K. Taking stem cells to the clinic: Major challenges. J Cell Biochem. 2008;105(6):1352-1360.
130. Lo B, Garan N. Historical perspective and evolving concerns for human research. Cancer Treat Res. 2007;132:1-10.
131. Chaerkady R, Kerr CL, Marimuthu A, et al. Temporal analysis of neural differentiation using quantitative proteomics (dagger). J Proteome Res. 2009;8(3):1315-1326.
132. Aasen T, Raya A, Barrero MJ, et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol. 2008;26(11):1276-1284.
133. Ali SH, DeCaprio JA. Cellular transformation by SV40 large T antigen: interaction with host proteins. Semin Cancer Biol. 2001;11(1):15-23.
134. Kerr DA, Llado J, Shamblott MJ, et al. Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury. J Neurosci. 2003;23(12):5131-5140. (Pubitemid 36793241)
135. Mueller D, Shamblott MJ, Fox HE, Gearhart JD, Martin LJ. Transplanted human embryonic germ cell-derived neural stem cells replace neurons and oligodendrocytes in the forebrain of neonatal mice with excitotoxic brain damage. J Neurosci Res. 2005;82(5):592-608. (Pubitemid 41740460)
136. Frimberger D, Morales N, Shamblott M, Gearhart JD, Gearhart JP, Lakshmanan Y. Human embryoid body-derived stem cells in bladder regeneration using rodent model. Urology. 2005;65(4):827-832. (Pubitemid 40523046)
137. Furth ME, Atala A. Stem cell sources to treat diabetes. J Cell Biochem. 2009;106(4):507-511.
138. Lindvall O, Kokaia Z. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol Sci. 2009;30(5):260-267.
139. Karussis D, Kassis I. The potential use of stem cells in multiple sclerosis: an overview of the preclinical experience. Clin Neurol Neurosurg. 2008;110(9):889-896.
140. Hwang NS, Varghese S, Lee HJ, et al. In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci U S A. 2008;105(52):20641-20646.
141. Hwang NS, Elisseeff J. Application of stem cells for articular cartilage regeneration. J Knee Surg. 2009;22(1):60-71.
142. Kroon E, Martinson LA, Kadoya K, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol. 2008;26(4):443-452. (Pubitemid 351501814)
143. Kehat I, Khimovich L, Caspi O, et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol. 2004;22(10):1282-1289. (Pubitemid 39341201)
144. Laflamme MA, Gold J, Xu C, et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol. 2005;167(3):663-671. (Pubitemid 41216352)
145. Xue T, Cho HC, Akar FG, et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation. 2005;111(1):11-20. (Pubitemid 40070838)
146. Leor J, Gerecht S, Cohen S, et al. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart. 2007;93(10):1278- 1284. (Pubitemid 47492921)
147. Ben-Hur T, Idelson M, Khaner H, et al. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells. 2004;22(7):1246-1255. (Pubitemid 39636402)
148. Roy NS, Cleren C, Singh SK, Yang L, Beal MF, Goldman SA. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med. 2006;12(11):1259- 1268. (Pubitemid 44706928)
149. Liu S, Qu Y, Stewart TJ, et al. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci U S A. 2000;97(11):6126-6131. (Pubitemid 30367534)
150. Keirstead HS, Nistor G, Bernal G, et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci. 2005;25(19):4694-4705. (Pubitemid 40664118)
151. Faulkner J, Keirstead HS. Human embryonic stem cell-derived oligodendrocyte progenitors for the treatment of spinal cord injury. Transpl Immunol. 2005;15(2):131-142.
152. Cloutier F, Siegenthaler MM, Nistor G, Keirstead HS. Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm. Regen Med. 2006;1(4):469-479.
153. Daadi MM, Maag AL, Steinberg GK. Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model. PLoS One. 2008;3(2):e1644.
154. Daadi MM, Lee SH, Arac A, et al. Functional Engraftment of the Medial Ganglionic Eminence Cells in Experimental Stroke Model. Cell Transplant. 2009;18(7):815-826.
155. Hicks AU, Lappalainen RS, Narkilahti S, et al. Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery. Eur J Neurosci. 2009;29(3):562-574.
156. Oyamada N, Itoh H, Sone M, et al. Transplantation of vascular cells derived from human embryonic stem cells contributes to vascular regeneration after stroke in mice. J Transl Med. 2008;6:54.
157. Soto-Gutierrez A, Kobayashi N, Rivas-Carrillo JD, et al. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol. 2006;24(11):1412-1419.
158. Vugler A, Carr AJ, Lawrence J, et al. Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp Neurol. 2008;214(2):347-361.
159. Nistor GI, Totoiu MO, Haque N, Carpenter MK, Keirstead HS. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia. 2005;49(3):385-396.
160. Aharonowiz M, Einstein O, Fainstein N, et al. Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis. PLoS One. 2008;3(9):e3145.
161. Couzin J. Biotechnology. Celebration and concern over US trial of embryonic stem cells. Science. 2009;323(5914):568.
162. Trounson A. New perspectives in human stem cell therapeutic research. BMC Med. 2009;7:29.
163. Wernig M, Zhao JP, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A. 2008;105(15):5856-5861.
164. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation. 2009;120(5):408-416.
165. Ebert AD, Yu J, Rose FF Jr, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. 2009;457(7227):277-280.
166. Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. 2008;321(5893):1218-1221.
167. Lee G, Papapetrou EP, Kim H, et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature. 2009;461(7262:402-406.
168. Maehr R, Chen S, Snitow M, et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A. 2009;106:15523-15524.
169. Hanna J, Wernig M, Markoulaki S, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science. 2007;318(5858):1920-1923.
170. Wang Y, Jiang Y, Liu S, Sun X, Gao S. Generation of induced pluripotent stem cells from human beta-thalassemia fibroblast cells. Cell Res. 2009;19(9):1120-1123.
171. Condic ML, Rao M. Regulatory issues for personalized pluripotent cells. Stem Cells. 2008;26(11):2753-2758.
172. Faden RR, Dawson L, Bateman-House AS, et al. Public stem cell banks: considerations of justice in stem cell research and therapy. Hastings Cent Rep. 2003;33(6):13-27.
173. Nakajima F, Tokunaga K, Nakatsuji N. Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy. Stem Cells. 2007;25(4):983-985.
174. Taylor CJ, Bolton EM, Pocock S, Sharples LD, Pedersen RA, Bradley JA. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet. 2005;366(9502):2019-2025.
175. Strulovici Y, Leopold PL, O'Connor TP, Pergolizzi RG, Crystal RG. Human embryonic stem cells and gene therapy. Mol Ther. 2007;15(5):850-866.
176. Harrison NJ, Baker D, Andrews PW. Culture adaptation of embryonic stem cells echoes germ cell malignancy. Int J Androl. 2007;30(4):275-281.
177. Draper JS, Smith K, Gokhale P, et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol. 2004;22(1):53-54.
178. Blum B, Benvenisty N. The tumorigenicity of human embryonic stem cells. Adv Cancer Res. 2008;100:133-158.
179. Spits C, Mateizel I, Geens M, et al. Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnol. 2008;26(12):1361-1363.
180. Greaves MF. Cord blood donor cell leukemia in recipients. Leukemia. 2006;20(9):1633-1634.
181. Barozzi P, Luppi M, Facchetti F, et al. Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med. 2003;9(5):554-561.
182. Avital I, Moreira AL, Klimstra DS, et al. Donor-derived human bone marrow cells contribute to solid organ cancers developing after bone marrow transplantation. Stem Cells. 2007;25(11):2903-2909.
183. Golfinopoulos V, Pentheroudakis G, Kamakari S, Metaxa-Mariatou V, Pavlidis N. Donor-derived breast cancer in a bone marrow transplantation recipient. Breast Cancer Res Treat. 2009;113(2):211-213.
184. Dubernard G, Aractingi S, Oster M, et al. Breast cancer stroma frequently recruits fetal derived cells during pregnancy. Breast Cancer Res. 2008;10(1):R14.
185. Roorda BD, ter Elst A, Kamps WA, de Bont ES. Bone marrow-derived cells
186. Johnson KL, Bianchi DW. Fetal cells in maternal tissue following pregnancy: what are the consequences? Hum Reprod Update. 2004;10(6):497-502.
187. Cha D, Khosrotehrani K, Kim Y, Stroh H, Bianchi DW, Johnson KL. Cervical cancer and microchimerism. Obstet Gynecol. 2003;102(4):774-781.
188. Amariglio N, Hirshberg A, Scheithauer BW, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009;6(2):e1000029.
189. Stilley CS, Ryan CM, Kondziolka D, Bender A, DeCesare S, Wechsler L. Changes in cognitive function after neuronal cell transplantation for basal ganglia stroke. Neurology. 2004;63(7):1320-1322.
190. Watson DJ, Longhi L, Lee EB, et al. Genetically modified NT2N human neuronal cells mediate long-term gene expression as CNS grafts in vivo and improve functional cognitive outcome following experimental traumatic brain injury. J Neuropathol Exp Neurol. 2003;62(4):368-380.
191. Kondziolka D, Wechsler L, Goldstein S, et al. Transplantation of cultured human neuronal cells for patients with stroke. Neurology. 2000;55(4):565-569.
192. Wechsler LR. Clinical trials of stroke therapy: which cells, which patients? Stroke. 2009;40(3 Suppl):S149-S151.